Evidence map›Paper›PMID 22383943›Full record

ArticlePloS one2012

Copy number variations due to large genomic deletion in X-linked chronic granulomatous disease.

Takashi Arai, Tsutomu Oh-ishi, Hideaki Yamamoto, Hiroyuki Nunoi, Junji Kamizono, Masahiko Uehara, Takeo Kubota, Takuya Sakurai, Takako Kizaki, Hideki Ohno

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Takashi AraiDepartment of Clinical Research, Saitama Children's Medical Center, Saitama, Japan.
Tsutomu Oh-ishi
Hideaki Yamamoto
Hiroyuki Nunoi
Junji Kamizono
Masahiko Uehara
Takeo Kubota
Takuya Sakurai
Takako Kizaki
Hideki Ohno
Kyorin University · JPSaitama Children's Medical Center · JPKitakyushu City Yahata Hospital · JPUniversity of Miyazaki · JPUniversity of Yamanashi · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in genes for any of the six subunits of NADPH oxidase cause chronic granulomatous disease (CGD), but almost 2/3 of CGD cases are caused by mutations in the X-linked CYBB gene, also known as NAD (P) H oxidase 2. Approximately 260 patients with CGD have been reported in Japan, of whom 92 were shown to have mutations of the CYBB gene and 16 to have chromosomal deletions. However, there has been very little detailed analysis of the range of the deletion or close understanding of the disease based on this. We therefore analyzed genomic rearrangements in X-linked CGD using array comparative genomic hybridization analysis, revealing the extent and the types of the deletion genes. The subjects were five Japanese X-linked CGD patients estimated to have large base deletions of 1 kb or more in the CYBB gene (four male patients, one female patient) and the mothers of four of those patients. The five Japanese patients were found to range from a patient exhibiting deletions only of the CYBB gene to a female patient exhibiting an extensive DNA deletion and the DMD and CGD phenotype manifested. Of the other three patients, two exhibited CYBB, XK, and DYNLT3 gene deletions. The remaining patient exhibited both a deletion encompassing DNA subsequent to the CYBB region following intron 2 and the DYNLT3 gene and a complex copy number variation involving the insertion of an inverted duplication of a region from the centromere side of DYNLT3 into the deleted region.

Indexed as

DNA Copy Number VariationsGenetic LinkageSequence DeletionCentromereChromosome DeletionChromosomes, Human, XComparative Genomic HybridizationDyneinsFemaleGene DuplicationGranulomatous Disease, ChronicHumansInfantIntronsJapanMaleCYBB protein, humanDyneinsDYNLT3 protein, humanMembrane GlycoproteinsNADPH Oxidase 2NADPH Oxidases

Identifiers

PMID22383943
PMCPMC3287986
OpenAlexW2023768964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.